Related Experiment Video
Updated: Jun 16, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Correlates of insulin injection omission
Mark Peyrot1, Richard R Rubin, Davida F Kruger
1Department of Sociology, Loyola University Maryland, Baltimore, Maryland, USA. mpeyrot@loyola.edu
Diabetes Care
|January 28, 2010
Summary
Many people with diabetes intentionally skip insulin injections due to factors like pain, embarrassment, and daily interference. Identifying these risks is crucial for improving treatment adherence and patient outcomes.
Area of Science:
- Endocrinology
- Diabetes Management
- Patient Adherence Research
Background:
- Insulin therapy is fundamental for managing type 1 and type 2 diabetes.
- Patient adherence to insulin injection regimens can be suboptimal.
- Understanding reasons for intentional insulin omission is critical for effective diabetes care.
Purpose of the Study:
- To identify demographic, disease-specific, and injection-related factors associated with the frequency of intentionally skipping insulin injections.
- To explore differences in these factors between patients with type 1 and type 2 diabetes.
Main Methods:
- An online survey was administered to 502 U.S. adults using insulin injections for diabetes.
- Multiple regression analysis was employed to determine independent risk factors for insulin omission.
Main Results:
- Over half of respondents reported intentional insulin omission, with 20% reporting regular omission.
- Key risk factors included younger age, lower income, higher education, type 2 diabetes, poor diet adherence, more frequent injections, and injection-related interference, pain, and embarrassment.
- Risk factors varied by diabetes type, with diet nonadherence more prevalent in type 1 and age, education, income, pain, and embarrassment in type 2 diabetes.
Conclusions:
- A significant number of patients intentionally omit insulin injections, necessitating identification and awareness of associated risk factors.
- Addressing injection-related issues like interference, pain, and embarrassment can improve adherence.
- Interventions targeting identified risk factors may enhance insulin regimen adherence and improve clinical outcomes.
More Related Videos
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...